{
  "id": 8002226,
  "title": "Roche turns to Dualitas to find new bispecific approaches for immunology",
  "url": "https://urgent.news/2026/09/17/roche-turns-to-dualitas-to-find-new-bispecific-approaches-for",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-17T10:00:54.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/roche-turns-to-dualitas-to-find-new-bispecific-approaches-for-immunology/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Roche is turning up the heat on its hunt for next-generation bispecific antibodies in a deal that will involve screening 300,000 new combinations for inflammatory and immunology conditions. The Swiss pharma is delivering $36.5 million ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "BioPharma Dive",
        "title": "Roche, Dualitas team up to find bispecific drugs for immune diseases",
        "url": "https://urgent.news/2026/09/17/roche-dualitas-team-up-to-find-bispecific-drugs-for-immune-diseases",
        "published": "2026-09-17T10:00:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}